Showing results (11-20 of 186) with videos related to
Sort By:
Pageof 19
The Lancet. Neurology|September 22, 2007
Clinical care of patients with amyotrophic lateral sclerosisAleksandar Radunović, Hiroshi Mitsumoto, P Nigel LeighBrain Communications|August 19, 2021
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2Ilaria Giovannelli, Nadhim Bayatti, Abigail Brown, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|March 15, 2011
The anatomy of cognitive impairment in amyotrophic lateral sclerosis: more than frontal lobe dysfunctionStella Tsermentseli, P Nigel Leigh, Laura H GoldsteinClinical and Experimental Immunology|November 18, 2022
IL-2-based approaches to Treg enhancementFfion Harris, Yoana Arroyo Berdugo, Timothy TreeNeuroscience Letters|March 9, 2004
Degradation properties of polyglutamine-expanded human androgen receptor in transfected cellsDaniel A Cullen, P Nigel Leigh, Jean-Marc GalloNeuroscience Letters|September 10, 2003
Protective effects of estrogens on polyglutamine-expanded androgen receptor aggregation in miceR Siobhan Darrington, P Nigel Leigh, Jean-Marc GalloPlos One|September 23, 2009
Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophyAmmar Al-Chalabi, Alexandra Dürr, Nicholas W Wood, et al.Frontiers in Neurology|November 2, 2019
Corrigendum: An Overview of MicroRNAs as Biomarkers of ALSGreig Joilin, P Nigel Leigh, Sarah F Newbury, et al.Frontiers in Neurology|March 23, 2019
An Overview of MicroRNAs as Biomarkers of ALSGreig Joilin, P Nigel Leigh, Sarah F Newbury, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 14, 2006
Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literatureKumar Abhinav, Ammar Al-Chalabi, Tibor Hortobagyi, et al.Pageof 19